[HTML][HTML] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T Kaburagi, H Satoh, K Hayashihara… - Oncology …, 2013 - spandidos-publications.com
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[PDF][PDF] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH, K HAYASHIHARA… - ONCOLOGY …, 2013 - researchgate.net
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T Kaburagi, H Satoh, K Hayashihara… - Oncology …, 2013 - pubmed.ncbi.nlm.nih.gov
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[PDF][PDF] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH, K HAYASHIHARA… - ONCOLOGY …, 2013 - Citeseer
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[PDF][PDF] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH… - ONCOLOGY …, 2013 - pdfs.semanticscholar.org
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH… - ONCOLOGY …, 2013 - ingentaconnect.com
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH, K HAYASHIHARA… - Oncology …, 2013 - search.proquest.com
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[PDF][PDF] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH, K HAYASHIHARA… - ONCOLOGY …, 2013 - scienceopen.com
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[HTML][HTML] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T Kaburagi, H Satoh, K Hayashihara… - Oncology …, 2013 - spandidos-publications.com
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …
[HTML][HTML] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
T KABURAGI, H SATOH, K HAYASHIHARA… - Oncology …, 2013 - ncbi.nlm.nih.gov
To evaluate the efficacy and safety of erlotinib for non-small cell lung cancer (NSCLC), we
performed a population-based observational study. The study involved 307 patients treated …
performed a population-based observational study. The study involved 307 patients treated …